David M. Shavelle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
David M. Shavelle has a total of 257 co-authors. Here are the top co-authors by number of shared publications:
Anilkumar Mehra
Univ Southern Calif, Div Cardiovasc Med, Los Angeles, CA 90007 USA
7 shared publicationsRay V. Matthews
Division of Cardiovascular Medicine, University of Southern California, Los Angeles, CA, United States of America
7 shared publicationsJoseph L. Thomas
David Geffen School of Medicine, University of California, Los Angeles, California; Division of Cardiology, Harbor UCLA Medical Center, Torrance, CA
4 shared publications- Leonardo C. Clavijo
Division of Cardiovascular Medicine, University of Southern California, Los Angeles, CA, United States of America
4 shared publications Leonardo Clavijo
Division of Cardiovascular Medicine, University of Southern California, Los Angeles, CA, United States of America
4 shared publications- Nichole Bosson
Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, CA, USA
4 shared publications
Latest Publications
- Open Access
Does Percutaneous Coronary Intervention Improve Survival for Out-Of-Hospital Cardiac Arrest Patients Receiving Extracorporeal Cardiopulmonary Resuscitation?
Introduction: Extracorporeal cardiopulmonary resuscitation (ECPR) can support patients who fail to respond to standard resuscitation for out-of-hospital cardiac arrest (OHCA) allowing further time for critical interventions and patient recovery. Although the majority of patients with refractory OHCA have coronary artery disease, the role of emergent percutaneous coronary intervention (PCI) is not clear. We evaluated the effect of PCI on survival to hospital discharge (SHD) in a contemporary cohort of patients with OHCA receiving ECPR. Methods: We performed a retrospective study using data from the Extracorporeal Life Support Organization (ELSO) registry. We included patients ≥18 years with OHCA due to a presumed cardiac etiology or an initial shockable rhythm who received ECPR from January 2020 to December 2023. Our primary outcome was SHD. We used inverse probability weighted matching to estimate the average treatment effect of PCI on SHD. We also performed a sensitivity analysis of patients most likely to benefit from PCI (witnessed arrest and no return of spontaneous circulation after five minutes of cardiopulmonary resuscitation. Results: Of 1336 OHCA patients receiving ECPR, 1131 were included in the final analysis after exclusions for age (n=31) and presumed non-cardiac or initial non-shockable rhythm (n=174). The median age was 55 years (IQR 44-62) and most patients were male (n=901, 80%). Twenty-one percent (n=243) received PCI; those patients who received PCI were slightly older (58 [IQR 48-63] vs 53 [IQR 42-62]) and more often male (n=212 [87%] vs n=689 [78%]). In the primary analysis, we found no significant difference in SHD for patients who received PCI compared to those who did not receive PCI (–3.56%, 95% CI –10.31 to 3.19; p-value 0.301). In our sensitivity analysis, we also did not find a significant difference in SHD for patients who received PCI compared to those who did not receive PCI (–4.52%, 95% CI – 12.42 to 2.46; p-value 0.246). Conclusion: In our registry-based study of refractory OHCA patients receiving ECPR, emergent PCI was not associated with a significant improvement in SHD. CLINICAL PERSPECTIVE: What Is New?: This is the largest cohort to date of patients with out-of-hospital cardiac arrest undergoing extracorporeal cardiopulmonary resuscitation and percutaneous coronary intervention; this study evaluates the effect of percutaneous coronary intervention on survival to hospital discharge. 2) What Are the Clinical Implications?: The lack of improvement in survival suggests that additional prospective studies evaluating the timing of percutaneous coronary intervention are needed to further clarify its role within the extracorporeal cardiopulmonary resuscitation care pathway.
Open AccessDoes Percutaneous Coronary Intervention Improve Survival for Out-Of-Hospital Cardiac Arrest Patients Receiving Extracorporeal Cardiopulmonary Resuscitation?
Introduction: Extracorporeal cardiopulmonary resuscitation (ECPR) can support patients who fail to respond to standard resuscitation for out-of-hospital cardiac arrest (OHCA) allowing further time for critical interventions and patient recovery. Although the majority of patients with refractory OHCA have coronary artery disease, the role of emergent percutaneous coronary intervention (PCI) is not clear. We evaluated the effect of PCI on survival to hospital discharge (SHD) in a contemporary cohort of patients with OHCA receiving ECPR. Methods: We performed a retrospective study using data from the Extracorporeal Life Support Organization (ELSO) registry. We included patients ≥18 years with OHCA due to a presumed cardiac etiology or an initial shockable rhythm who received ECPR from January 2020 to December 2023. Our primary outcome was SHD. We used inverse probability weighted matching to estimate the average treatment effect of PCI on SHD. We also performed a sensitivity analysis of patients most likely to benefit from PCI (witnessed arrest and no return of spontaneous circulation after five minutes of cardiopulmonary resuscitation. Results: Of 1336 OHCA patients receiving ECPR, 1131 were included in the final analysis after exclusions for age (n=31) and presumed non-cardiac or initial non-shockable rhythm (n=174). The median age was 55 years (IQR 44-62) and most patients were male (n=901, 80%). Twenty-one percent (n=243) received PCI; those patients who received PCI were slightly older (58 [IQR 48-63] vs 53 [IQR 42-62]) and more often male (n=212 [87%] vs n=689 [78%]). In the primary analysis, we found no significant difference in SHD for patients who received PCI compared to those who did not receive PCI (–3.56%, 95% CI –10.31 to 3.19; p-value 0.301). In our sensitivity analysis, we also did not find a significant difference in SHD for patients who received PCI compared to those who did not receive PCI (–4.52%, 95% CI – 12.42 to 2.46; p-value 0.246). Conclusion: In our registry-based study of refractory OHCA patients receiving ECPR, emergent PCI was not associated with a significant improvement in SHD. CLINICAL PERSPECTIVE: What Is New?: This is the largest cohort to date of patients with out-of-hospital cardiac arrest undergoing extracorporeal cardiopulmonary resuscitation and percutaneous coronary intervention; this study evaluates the effect of percutaneous coronary intervention on survival to hospital discharge. 2) What Are the Clinical Implications?: The lack of improvement in survival suggests that additional prospective studies evaluating the timing of percutaneous coronary intervention are needed to further clarify its role within the extracorporeal cardiopulmonary resuscitation care pathway.
- Open Access
- 6 January 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (1) , e040879
Screening Patients for Elevated Left Ventricular End‐Diastolic Pressure Using a Novel Noninvasive Brachial Cuff–ECG System: A Multicenter Validation Study
Background: Measurement of left ventricular end‐diastolic pressure (LVEDP) is an established diagnostic method to evaluate heart failure but requires an invasive procedure. A noninvasive technique for detecting elevated LVEDP would improve the diagnosis of heart failure. Herein, we present the results of a multicenter study to validate a noninvasive system to detect elevated LVEDP. Methods: The Vivio System includes a modified blood pressure cuff and single‐lead ECG to capture brachial artery waveforms. A model was created to identify patients with elevated LVEDP (>18 mm Hg). For the invasive cohort, all patients were referred for coronary angiography and left heart catheterization for clinical indications. A group of 321 patients with no significant health problems were enrolled as a control cohort. Invasive LVEDP measurements were performed using Millar catheters. The training data set (n=262) contained 101 patients with LVEDP measurements (n=44 with LVEDP >18 mm Hg) and 161 controls. The validation data set (n=155) contained 75 patients with LVEDP measurements (n=40 with LVEDP >18 mm Hg) and 80 controls. Results: Leave‐one‐out cross‐validation on the training data set yielded a sensitivity of 0.84 (95% CI, 0.70–0.93]) and a specificity of 0.84 (95% CI, 0.79–0.89). The validation data set showed a sensitivity of 0.80 (95% CI, 0.64–0.91) and a specificity of 0.83 (95% CI, 0.75–0.90). Conclusions: The Vivio System can accurately detect elevated LVEDP and has the potential to significantly improve early detection of heart failure in the outpatient setting.
- 6 January 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (1) , e040879
Open AccessScreening Patients for Elevated Left Ventricular End‐Diastolic Pressure Using a Novel Noninvasive Brachial Cuff–ECG System: A Multicenter Validation Study
Background: Measurement of left ventricular end‐diastolic pressure (LVEDP) is an established diagnostic method to evaluate heart failure but requires an invasive procedure. A noninvasive technique for detecting elevated LVEDP would improve the diagnosis of heart failure. Herein, we present the results of a multicenter study to validate a noninvasive system to detect elevated LVEDP. Methods: The Vivio System includes a modified blood pressure cuff and single‐lead ECG to capture brachial artery waveforms. A model was created to identify patients with elevated LVEDP (>18 mm Hg). For the invasive cohort, all patients were referred for coronary angiography and left heart catheterization for clinical indications. A group of 321 patients with no significant health problems were enrolled as a control cohort. Invasive LVEDP measurements were performed using Millar catheters. The training data set (n=262) contained 101 patients with LVEDP measurements (n=44 with LVEDP >18 mm Hg) and 161 controls. The validation data set (n=155) contained 75 patients with LVEDP measurements (n=40 with LVEDP >18 mm Hg) and 80 controls. Results: Leave‐one‐out cross‐validation on the training data set yielded a sensitivity of 0.84 (95% CI, 0.70–0.93]) and a specificity of 0.84 (95% CI, 0.79–0.89). The validation data set showed a sensitivity of 0.80 (95% CI, 0.64–0.91) and a specificity of 0.83 (95% CI, 0.75–0.90). Conclusions: The Vivio System can accurately detect elevated LVEDP and has the potential to significantly improve early detection of heart failure in the outpatient setting.
- Open Access
- 2 September 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (17) , e039975
Periprocedural Results and Right Ventricular Outcomes of Computer Assisted Vacuum Thrombectomy Treatment of Acute Pulmonary Embolism: Interim Analysis of 300 Patients From the STRIKE‐PE Study
Background: Pulmonary embolism (PE) can be a life‐threatening condition. Endovascular treatment is emerging as a promising treatment to restore hemodynamic stability and reverse right ventricular (RV) dysfunction in PE; however, more studies are needed to elucidate the effects on the right ventricle after endovascular treatment. This analysis reports the effects of computer assisted vacuum thrombectomy on RV function. Methods: Eligible patients for the single‐arm, prospective, international, multicenter STRIKE‐PE (A Prospective, Multicenter Study of the Indigo Aspiration System Seeking to Evaluate the Long‐Term Safety and Outcomes of Treating Pulmonary Embolism) cohort study are adults with acute PE with symptoms for ≤14 days and an RV/left ventricular ratio of ≥0.9 who are treated with computer assisted vacuum thrombectomy. Reported here are periprocedural and RV outcomes of the initial 300 patients of STRIKE‐PE, to provide insights into effects on RV function after computer assisted vacuum thrombectomy. Results: Patients were classified with high‐risk (5.7%), intermediate‐high‐risk (84.7%), or intermediate‐low‐risk (9.7%) PE. Median thrombectomy time was 30 minutes. Mean on‐table systolic pulmonary artery pressure decreased from 51.7 mm Hg to 41.3 mm Hg, a 19.1% reduction ( P P P P <0.001). Conclusions: This interim analysis demonstrates that computer assisted vacuum thrombectomy safely and expeditiously improves hemodynamic status, RV function, and perceived dyspnea. Registration: URL: https://clinicaltrials.gov ; Unique Identifier: NCT04798261.
- 2 September 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (17) , e039975
Open AccessPeriprocedural Results and Right Ventricular Outcomes of Computer Assisted Vacuum Thrombectomy Treatment of Acute Pulmonary Embolism: Interim Analysis of 300 Patients From the STRIKE‐PE Study
Background: Pulmonary embolism (PE) can be a life‐threatening condition. Endovascular treatment is emerging as a promising treatment to restore hemodynamic stability and reverse right ventricular (RV) dysfunction in PE; however, more studies are needed to elucidate the effects on the right ventricle after endovascular treatment. This analysis reports the effects of computer assisted vacuum thrombectomy on RV function. Methods: Eligible patients for the single‐arm, prospective, international, multicenter STRIKE‐PE (A Prospective, Multicenter Study of the Indigo Aspiration System Seeking to Evaluate the Long‐Term Safety and Outcomes of Treating Pulmonary Embolism) cohort study are adults with acute PE with symptoms for ≤14 days and an RV/left ventricular ratio of ≥0.9 who are treated with computer assisted vacuum thrombectomy. Reported here are periprocedural and RV outcomes of the initial 300 patients of STRIKE‐PE, to provide insights into effects on RV function after computer assisted vacuum thrombectomy. Results: Patients were classified with high‐risk (5.7%), intermediate‐high‐risk (84.7%), or intermediate‐low‐risk (9.7%) PE. Median thrombectomy time was 30 minutes. Mean on‐table systolic pulmonary artery pressure decreased from 51.7 mm Hg to 41.3 mm Hg, a 19.1% reduction ( P P P P <0.001). Conclusions: This interim analysis demonstrates that computer assisted vacuum thrombectomy safely and expeditiously improves hemodynamic status, RV function, and perceived dyspnea. Registration: URL: https://clinicaltrials.gov ; Unique Identifier: NCT04798261.
- 26 November 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 213, 93-98
Association of the COVID-19 Pandemic on Treatment Times for ST-Elevation Myocardial Infarction: Observations from the Los Angeles County Regional System
- 26 November 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 213, 93-98
Association of the COVID-19 Pandemic on Treatment Times for ST-Elevation Myocardial Infarction: Observations from the Los Angeles County Regional System
- Open Access
- 28 February 2023
- Published by Elsevier in Heart Failure Clinics
- Vol. 19 (2) , 231-240
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care
- 28 February 2023
- Published by Elsevier in Heart Failure Clinics
- Vol. 19 (2) , 231-240
Open AccessImpact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care
- 24 September 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 184, 90-95
Ambulatory Pulmonary Artery Pressures After Transcatheter Edge-to-Edge Repair of the Mitral Valve in Patients With Heart Failure and Mitral Regurgitation
- 24 September 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 184, 90-95
Ambulatory Pulmonary Artery Pressures After Transcatheter Edge-to-Edge Repair of the Mitral Valve in Patients With Heart Failure and Mitral Regurgitation
- 23 January 2022
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 99 (4) , 1289-1299
Contemporary treatment of below‐the‐knee peripheral arterial disease in patients with chronic limb threatening ischemia: Observations from the Vascular Quality Initiative
Objective: We sought to determine trends in percutaneous transluminal angioplasty (PTA) versus non‐PTA interventions over time, as well as factors that influence the decision for non‐PTA intervention.Background: Although the optimal strategy for revascularization in patients with below‐the‐knee (BTK) chronic limb‐threatening ischemia (CLTI) remains under investigation, PTA has been the preferred endovascular approach. Recently, there has been an increase in the use of non‐PTA approaches for revascularization.Methods: We performed a retrospective analysis of the Vascular Quality Initiative. Between 2011 and 2020, a total of 23,850 procedures corresponding to 33,098 arteries in 19,404 patients with CLTI were included. After application of exclusion criteria and removal of missing variables, 18,644 arteries were included in the study cohort. The primary analysis was factors associated with receiving non‐PTA intervention. Secondary analysis included trends in PTA versus non‐PTA intervention over time.Results: Throughout the study period, the majority of interventions (72%) were PTA alone. The percentage of non‐PTA interventions, on a per‐artery basis, increased over the study period from 18% to 33%, p < 0.01. Advanced age, increasing TransAtlantic Inter‐Society Consensus classification, and concomitant above‐the‐knee disease were associated with an increased likelihood for non‐PTA intervention. In contrast, longer lesion length, insulin‐dependent diabetes mellitus, bilateral disease, and discharge to location other than home were associated with an increased likelihood of PTA.Conclusions: We observed a significant increase in the percentage of non‐PTA interventions for patients with CLTI requiring BTK interventions over the last decade, with lesion‐ and patient‐specific characteristics associated with the type of endovascular approach.
- 23 January 2022
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 99 (4) , 1289-1299
Contemporary treatment of below‐the‐knee peripheral arterial disease in patients with chronic limb threatening ischemia: Observations from the Vascular Quality Initiative
Objective: We sought to determine trends in percutaneous transluminal angioplasty (PTA) versus non‐PTA interventions over time, as well as factors that influence the decision for non‐PTA intervention.Background: Although the optimal strategy for revascularization in patients with below‐the‐knee (BTK) chronic limb‐threatening ischemia (CLTI) remains under investigation, PTA has been the preferred endovascular approach. Recently, there has been an increase in the use of non‐PTA approaches for revascularization.Methods: We performed a retrospective analysis of the Vascular Quality Initiative. Between 2011 and 2020, a total of 23,850 procedures corresponding to 33,098 arteries in 19,404 patients with CLTI were included. After application of exclusion criteria and removal of missing variables, 18,644 arteries were included in the study cohort. The primary analysis was factors associated with receiving non‐PTA intervention. Secondary analysis included trends in PTA versus non‐PTA intervention over time.Results: Throughout the study period, the majority of interventions (72%) were PTA alone. The percentage of non‐PTA interventions, on a per‐artery basis, increased over the study period from 18% to 33%, p < 0.01. Advanced age, increasing TransAtlantic Inter‐Society Consensus classification, and concomitant above‐the‐knee disease were associated with an increased likelihood for non‐PTA intervention. In contrast, longer lesion length, insulin‐dependent diabetes mellitus, bilateral disease, and discharge to location other than home were associated with an increased likelihood of PTA.Conclusions: We observed a significant increase in the percentage of non‐PTA interventions for patients with CLTI requiring BTK interventions over the last decade, with lesion‐ and patient‐specific characteristics associated with the type of endovascular approach.
- 1 November 2021
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 14 (11) , e008446
Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure
- 1 November 2021
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 14 (11) , e008446
Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure
- Open Access
- 14 October 2021
- Published by Herald Scholarly Open Access in Angiology & Vascular Surgery
- Vol. 6 (2) , 1-5
Mathematical Modeling of Blood Flow to Evaluate the Hemodynamic Significance of Peripheral Vascular Lesions
Background: Evaluating the severity of peripheral artery lesions is challenging. Image-based blood flow modeling from peripheral Computed Tomographic Angiography (pCTA) may provide a non-invasive method to determine the hemodynamic significance of lesions. This pilot study evaluates the performance of pCTA-based blood flow modeling in diagnosing functionally significant peripheral lesions in comparison with Digital Subtraction Angiography (DSA). Methods: Ten patients undergoing DSA and pCTA were included. The peripheral arteries were divided into 8 segments per extremity and stenosis severity was graded by visual estimation from DSA. Each segment was graded 0 to IV (normal, mildly-stenotic, moderately-stenotic, severely-stenotic, occluded) or non-evaluable. Independent from DSA review, a Resting Pressure Drop (RPD) and an Exercise Pressure Drop (ExPD) for each segment was calculated from pCTA-based blood flow modeling. A functionally significant (FS) lesion was defined as grade III or IV by DSA and RPD > 5 mmHg from pCTA-based modeling. Analysis was repeated with an ExPD > 20 mmHg. Sensitivity, specificity and accuracy were calculated for RPD > 5 mmHg and ExPD > 20 mmHg using DSA as the standard. Results: Mean age was 52±16 years, 4 patients were male, 8 patients presented with critical limb ischemia, mean ankle brachial index was 0.60±0.29, and 66 arterial segments were available for both assessment methods. Twenty-two segments had FS lesions by DSA. Using an RPD > 5 mmHg, sensitivity was 80%, specificity was 85% and accuracy was 79%. Using an ExPD > 20 mmHg, sensitivity was 84%, specificity was 89% and accuracy was 88%. Conclusion: Use of a resting pressure drop > 5 mmHg and an exercise pressure drop > 20 mmHg, measured by blood flow modeling from CT angiography, can accurately identify functionally significant stenosis in patients with peripheral vascular disease. This information motivates the need for a larger-scale prospective imaging trial to further validate this novel non-invasive approach.
- 14 October 2021
- Published by Herald Scholarly Open Access in Angiology & Vascular Surgery
- Vol. 6 (2) , 1-5
Open AccessMathematical Modeling of Blood Flow to Evaluate the Hemodynamic Significance of Peripheral Vascular Lesions
Background: Evaluating the severity of peripheral artery lesions is challenging. Image-based blood flow modeling from peripheral Computed Tomographic Angiography (pCTA) may provide a non-invasive method to determine the hemodynamic significance of lesions. This pilot study evaluates the performance of pCTA-based blood flow modeling in diagnosing functionally significant peripheral lesions in comparison with Digital Subtraction Angiography (DSA). Methods: Ten patients undergoing DSA and pCTA were included. The peripheral arteries were divided into 8 segments per extremity and stenosis severity was graded by visual estimation from DSA. Each segment was graded 0 to IV (normal, mildly-stenotic, moderately-stenotic, severely-stenotic, occluded) or non-evaluable. Independent from DSA review, a Resting Pressure Drop (RPD) and an Exercise Pressure Drop (ExPD) for each segment was calculated from pCTA-based blood flow modeling. A functionally significant (FS) lesion was defined as grade III or IV by DSA and RPD > 5 mmHg from pCTA-based modeling. Analysis was repeated with an ExPD > 20 mmHg. Sensitivity, specificity and accuracy were calculated for RPD > 5 mmHg and ExPD > 20 mmHg using DSA as the standard. Results: Mean age was 52±16 years, 4 patients were male, 8 patients presented with critical limb ischemia, mean ankle brachial index was 0.60±0.29, and 66 arterial segments were available for both assessment methods. Twenty-two segments had FS lesions by DSA. Using an RPD > 5 mmHg, sensitivity was 80%, specificity was 85% and accuracy was 79%. Using an ExPD > 20 mmHg, sensitivity was 84%, specificity was 89% and accuracy was 88%. Conclusion: Use of a resting pressure drop > 5 mmHg and an exercise pressure drop > 20 mmHg, measured by blood flow modeling from CT angiography, can accurately identify functionally significant stenosis in patients with peripheral vascular disease. This information motivates the need for a larger-scale prospective imaging trial to further validate this novel non-invasive approach.
- 1 August 2021
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 33 (8) , E614-E618
Use of the CardioHELP Device for Temporary Hemodynamic Support During High-Risk Percutaneous Coronary Intervention
Fifteen consecutive patients receiving the CardioHELP device for elective, high-risk PCI treated at 2 medical centers were included. Patients with cardiogenic shock, cardiac arrest, or non-PCI indications for ECMO were excluded. Baseline demographics, angiographic variables, procedure-related variables, and in-hospital events were collected. Original Contribution from Journal of Invasive Cardiology. High-risk PCI Hemodynamic support extracorporeal membrane oxygenation
- 1 August 2021
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 33 (8) , E614-E618
Use of the CardioHELP Device for Temporary Hemodynamic Support During High-Risk Percutaneous Coronary Intervention
Fifteen consecutive patients receiving the CardioHELP device for elective, high-risk PCI treated at 2 medical centers were included. Patients with cardiogenic shock, cardiac arrest, or non-PCI indications for ECMO were excluded. Baseline demographics, angiographic variables, procedure-related variables, and in-hospital events were collected. Original Contribution from Journal of Invasive Cardiology. High-risk PCI Hemodynamic support extracorporeal membrane oxygenation